A 3D pocket-aware lead optimization model with knowledge guidance and its application for discovery of new glutaminyl cyclase inhibitors
Briefings in Bioinformatics · 02.07.2025 · 26 (4)
DOI: 10.1093/bib/bbaf345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 16.07.2025. Verfasst von Anjie Qiao und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Engineering, Sun Yat-sen University, No. 132 Waihuan East Road, Guangzhou 510006, Guangdong, China. Hauptthemen laut MEDLINE: Aminoacyltransferases, Drug Discovery, Enzyme Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong-Hong Kong Technology Cooperation Funding Scheme.
Abstract (Originalsprache)
Lead optimization, aimed at improving binding affinity or other properties of hit compounds, is a crucial task in drug discovery. Though deep learning-based 3D generative models showed promise in enhancing the efficiency of de novo drug design recently, less research and attention has garnered for structure-based lead optimization. Herein, we propose a 3D pocket-aware diffusion model named Diffleop, which explicitly incorporates the knowledge of protein-ligand binding affinity and information on covalent bonds to guide the denoising sampling process for lead optimization with enhanced binding affinity and rational properties. Specifically, the bond constraint is achieved through diffusion on fully connected molecular graphs, and the determination of atom positions, atom and bond types in each sampling step is guided by the gradient of the binding affinity that is predicted through fitting with an E(3)-equivariant expert network. The comprehensive evaluations indicated that Diffleop outperforms baseline models on lead optimization with higher affinity and more binding interactions, and can generate more drug-like molecules with more rational structures. Diffleop was further applied to optimize 5-methyl-1H-imidazole, our newly discovered lead compound targeting human glutaminyl cyclases (QCs). Three synthesized compounds exhibit substantially improved inhibitory activities against QCs, with the most effective one showing an IC50 value of 8 nM and 3.5-fold better than clinical candidate PQ912.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Engineering, Sun Yat-sen University, No. 132 Waihuan East Road, Guangzhou 510006, Guangdong, China.
- West China School of Pharmacy, Sichuan University, No. 17 Southern Renmin Road, Chengdu 610041, Sichuan, China.
- School of Pharmaceutical Science, Sun Yat-sen University, No. 132 Waihuan East Road, Guangzhou 510006, Guangdong, China.
- Guangzhou National Laboratory, No. 9 XinDaoHuanBei Road, Guangzhou International Bio Island, Guangzhou 510005, Guangdong, China.
- Global Institute of Future Technology, No. 800 Dongchuan Road, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Mingyuan Xu, Jiancong Xie, Yuedong Yang, Guo-Bo Li, Jinping Lei
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong-Hong Kong Technology Cooperation Funding Scheme
- startup and R&D Program of Guangzhou National Laboratory
Zitieren
APA
Qiao, A., Chen, Y., Xie, J., Huang, W., Zhang, H., Deng, Q., Rao, J., Deng, J., Meng, F., Wang, Z., Xu, M., Chen, H., Xie, J., Zheng, S., Yang, Y., Li, G. B., & Lei, J. (2025). A 3D pocket-aware lead optimization model with knowledge guidance and its application for discovery of new glutaminyl cyclase inhibitors. Briefings in Bioinformatics, 26(4). https://doi.org/10.1093/bib/bbaf345
Vancouver
Qiao A, Chen Y, Xie J, Huang W, Zhang H, Deng Q, et al. A 3D pocket-aware lead optimization model with knowledge guidance and its application for discovery of new glutaminyl cyclase inhibitors. Briefings in Bioinformatics. 2025;26(4). doi:10.1093/bib/bbaf345
BibTeX
@article{Qiao2025,
author = {Qiao, Anjie and Chen, Yuting and Xie, Junjie and Huang, Weifeng and Zhang, Hao and Deng, Qirui and Rao, Jiahua and Deng, Ji and Meng, Fanbo and Wang, Zhen and Xu, Mingyuan and Chen, Hongming and Xie, Jiancong and Zheng, Shuangjia and Yang, Yuedong and Li, Guo-Bo and Lei, Jinping},
title = {A 3D pocket-aware lead optimization model with knowledge guidance and its application for discovery of new glutaminyl cyclase inhibitors},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {4},
doi = {10.1093/bib/bbaf345}
}
EUVIMED